Navigation

Thrombocytopenic purpura - eltrombopag

Eltrombopag for the treatment of chronic immune or idiopathic thrombocytopenic purpura

Status: History
Expected date of issue: October 2010
Referral date: June 2008
Process: STA
Topic area:
  • Blood and immune system
 

NICE project team

Executive Lead: Peter Littlejohns
Technical Lead: Gabriel Rogers
Communications manager: Shalu Kanal
Project manager: Kate Moore
Assessment Group / Evidence Review Group: Aberdeen HTA Group
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 9 October 2009
1st appraisal committee meeting: 27 January 2010
2nd appraisal committee meeting 27 July 2010
Top


 

Consultees and commentators

Consultees Commentators (no right to submit or appeal)

Manufacturers/sponsors

  • GlaxoSmithKline (eltrombopag)

Patient/carer groups

  • ITP Support Association

Professional groups

  • British Society for Haematology
  • Royal College of Nursing
  • Royal College of Pathologists
  • Royal College of Physicians

Others

  • Department of Health
  • Welsh Assembly Government

General

  • NHS Quality Improvement Scotland

Comparator manufacturer(s)

  • Roche Products (mycophenolate mofetil, rituximab)
  • Sanofi-aventis (danazol)

Relevant research groups

  • None

Evidence Review Group

  • Aberdeen HTA Group
  • National Institute for Health Research Health Technology Assessment Programme

Associated Guideline Groups

  • None

Associated Public Health Groups

  • None

Top


 

Project history

Date Update
28 May 2010 Further to the update of the 10 March 2010 we are now in a position to release the decision made by the committee and the evidence documentation related to. The Appraisals Committee will next meet on 27 July 2010 to discuss the above appraisal.
10 March 2010 The manufacturer of the drug has informed us that the date on which this drug will be launched in the UK has not been finalised and the final price of the drug has not been formally announced. Therefore, in line with the Singe Technology Appraisal (STA) Process Guide, we cannot release the decision agreed by the committee and the evidence documentation related to the appraisal at this time.
Top


 

Key documents

This page was last updated: 08 February 2011

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.